- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.07. | VENUS MEDTECH-B (02500): LAPSE OF THE SUBSCRIPTION AGREEMENT IN RELATION TO THE PROPOSED ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE | 1 | HKEx | ||
| 02.07. | VENUS MEDTECH-B (02500): INSIDE INFORMATION POTENTIAL SUBSCRIPTION OF NEW SHARES AND NEW CONVERTIBLE BONDS BY INTENDED INVESTORS | 2 | HKEx | ||
| 25.06. | VENUS MEDTECH-B (02500): POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 03.06. | VENUS MEDTECH-B (02500): PROXY FORM FOR USE AT THE 2025 ANNUAL GENERAL MEETING | - | HKEx | ||
| 03.06. | VENUS MEDTECH-B (02500): NOTICE OF 2025 ANNUAL GENERAL MEETING | - | HKEx | ||
| 03.06. | VENUS MEDTECH-B (02500): (1) 2025 ANNUAL REPORT (2) WORK REPORT OF THE BOARD FOR 2025 (3) WORK REPORT OF THE SUPERVISORY COMMITTEE FOR 2025 (4) PROFIT ... | 3 | HKEx | ||
| 26.05. | Venus Medtech Hosts Inaugural Global Partner Summit in Paris | 434 | PR Newswire | Company highlights international growth strategy, expanding structural heart portfolio, and commercialization prioritiesPARIS, May 26, 2026 /PRNewswire/ -- Venus Medtech convened its inaugural... ► Artikel lesen | |
| 19.05. | VENUS MEDTECH-B (02500): EXCHANGE'S DISCIPLINARY ACTION AGAINST FORMER COMPANY SECRETARY OF VENUS MEDTECH (HANGZHOU) INC. (STOCK CODE: 2500) | 1 | HKEx | ||
| VENUS MEDTECH Aktie jetzt für 0€ handeln | |||||
| 15.05. | VENUS MEDTECH-B (02500): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 15.05. | VENUS MEDTECH-B (02500): RESIGNATION OF A DIRECTOR | - | HKEx | ||
| 06.05. | VENUS MEDTECH-B (02500): CHANGE OF COMPANY SECRETARY AND AUTHORIZED REPRESENTATIVES | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): 2025 ANNUAL REPORT | 1 | HKEx | ||
| 31.03. | VENUS MEDTECH-B (02500): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 | 1 | HKEx | ||
| 19.03. | VENUS MEDTECH-B (02500): DATE OF BOARD MEETING | 3 | HKEx | ||
| 22.01. | VENUS MEDTECH-B (02500): FURTHER ANNOUNCEMENT IN RELATION TO THE PATENT INFRINGEMENT LAWSUIT | 1 | HKEx | ||
| 17.11.25 | Venus Medtech (Hangzhou) Inc.: Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion | 654 | PR Newswire | Exciting Data on Cardiovalve Tricuspid Valve Replacement Device Presented at PCR London Valves 2025 meeting.
LONDON, Nov. 17, 2025 /PRNewswire/ -- Venus Medtech... ► Artikel lesen | |
| 25.10.25 | Venus Medtech (Hangzhou) Inc.: Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement | 751 | PR Newswire | The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch
HANGZHOU, China, Oct. 25, 2025 /PRNewswire/... ► Artikel lesen | |
| 05.08.25 | Venus Medtech (Hangzhou) Inc.: Court Sides with Cardiovalve in Edwards patent spat | 352 | PR Newswire | HANGZHOU, China, Aug. 5, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. ("Venus Medtech", Stock Code: 02500.HK) recently announced a decisive legal victory for its wholly-owned subsidiary... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADVANCED BIOMED | 9,000 | +1,12 % | Morning Market Movers: Baiya International Group, Globavend, Advanced Biomed, Sadot Group See Big Swings | CANBERA (dpa-AFX) - At 7:25 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 70,54 | +0,06 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600 | NEW YORK, July 14, 2026 /PRNewswire/ -- S&P SmallCap 600 constituent BrightSpring Health Services Inc. (NASD: BTSG) will replace Chart Industries Inc. (NYSE: GTLS)... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 26,260 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 11,340 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,090 | -0,05 % | Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now | ||
| FRESENIUS MEDICAL CARE | 42,770 | +1,11 % | BERNSTEIN RESEARCH stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung von Fresenius Medical Care (FMC) mit "Market-Perform" und einem Kursziel von 44,65 Euro gestartet. Mit der Markteinführung... ► Artikel lesen | |
| FRESENIUS | 43,320 | +1,48 % | DEUTSCHE BANK RESEARCH stuft Fresenius SE auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Fresenius auf "Buy" mit einem Kursziel von 55 Euro belassen. Falko Friedrichs rechnet mit einem guten zweiten Quartal des... ► Artikel lesen | |
| BILLIONTOONE | 125,20 | +0,05 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,600 | -1,65 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 38 Euro auf "Neutral" belassen. In der Radiotherapie heiße es nicht mehr nur... ► Artikel lesen | |
| GENEDX | 60,73 | +0,13 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| AVEANNA HEALTHCARE | 9,690 | 0,00 % | Aveanna Healthcare (AVAH): Best Future Stocks to Buy Under $10 | ||
| CARL ZEISS MEDITEC | 27,800 | -3,27 % | DEUTSCHE BANK RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Carl Zeiss Meditec von 30 auf 28 Euro gesenkt und die Einstufung auf "Hold" belassen. In einem am Dienstag vorliegenden Ausblick... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,220 | 0,00 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| PROGYNY | 31,750 | -0,06 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| HEARTFLOW | 24,540 | -0,08 % | Stifel reiterates HeartFlow stock rating after cardiology meeting |
VENUS MEDTECH HANGZHOU INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENUS MEDTECH HANGZHOU INC finden Sie auf Wallstreet Online.